Order: Aurora Cannabis Inc. and Cannimed Therapeutics Inc.

FILE NO.: 2017-71

IN THE MATTER OF
AURORA CANNABIS INC.

- and -

IN THE MATTER OF
CANNIMED THERAPEUTICS INC

D. Grant Vingoe, Vice-Chair and Chair of the Panel

December 8, 2017

ORDER

(Subsection 3.5(2) of the
Securities Act, RSO 1990, c S.5)

WHEREAS on December 8, 2017, the Ontario Securities Commission held a hearing in writing to consider the Applicant’s Motion dated December 7, 2017 requesting that the Application be heard in a joint hearing between the Financial and Consumer Affairs Authority of Saskatchewan (the “FCAAS”) and the Commission pursuant to section 22 of the Financial and Consumer Affairs Authority of Saskatchewan Act, SS 2012, c F-13.5, Rule 30 of the Commission’s Rules of Procedure and Forms (2017), 40 OSCB 8988(the “Commission’s Rules”) and National Policy 11-203 – Process for Exemptive Relief Applications in Multiple Jurisdictions;

ON READING the Applicant’s Motion, including the Affidavit of L. Rafi sworn December 7, 2017, and considering the consents Staff of the FCAAS and Staff of the Commission and considering that CanniMed Therapeutics Inc. provided a conditional consent that was not acceptable to the other parties and did not file any responding motion materials;

IT IS ORDERED THAT pursuant to subsection 3.5(2) of the Securities Act, RSO 1990, c S.5 and Rule 30 of the Commission’s Rules, the Application will be heard jointly with the FCAAS.